Superbrewed Food Launches Shelf-Stable Thryvia Postbiotic
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
COPENHAGEN, Denmark, August 12, 2026 Novonesis announced the launch of Optiva® Triticum, a new biosolution designed to help pasta...
Rehovot, Israel, May 25, 2026 Amai Proteins has announced a major regulatory breakthrough after receiving approval from the Singapore...
VANCOUVER, Canada, March 30, 2026 Beyond Oil Ltd., a leading food technology company, announced its strategic expansion into the...
MISSISSAUGA, ON – November 13, 2025 — Maple Leaf Foods has launched its new Mighty Protein Meat Sticks, a...
